LOS ANGELES--(BUSINESS WIRE)--Nov 8, 2012--Fidelis Diagnostics, Inc., a rapidly growing healthcare company providing innovative diagnostic services nationally, today announced it is offering turnkey sleep disorder solutions for physicians and their patients that encompass the initial diagnosis of Obstructive Sleep Apnea (OSA), as well as the ongoing medical management of the disease.
“By establishing a nationwide network of specialist treatment providers for OSA, Fidelis Diagnostics has significantly expanded its scope of services. These strategic relationships make the initial diagnosis of OSA easier and more convenient for physicians and their patients, and it also bridges the gap between the initial diagnosis of OSA and its clinical treatment and aftercare,” said Amir London, COO of Fidelis Diagnostics, Inc. “By working with dedicated providers, we now provide a continuum of care to ensure the health and well-being of patients suffering from sleep disorders through proper diagnosis followed by consistent on-going treatment to optimize their therapy.” Fidelis Diagnostics offers a more convenient way to diagnose sleep apnea with Home Sleep Studies using WatchPAT, an innovative, clinically proven, FDA-approved in home sleep study device providing accurate detection of sleep apnea. Used in the comfort of the patient’s own bedroom (an environment that best reflects the usual sleep habits), it provides more reliable and precise results than those obtained in traditional sleep labs.
It is estimated that Obstructive Sleep Apnea (OSA) affects nearly 23 million working Americans and can have hazardous effects on health and quality of life - ranging from high blood pressure and other cardiovascular disorders to cognitive weakening, headaches, degradation of social and work-related activities, and increased risk of car and work-related accidents. Now those likely to suffer from sleep disorders can be more conveniently tested and then followed with a course of treatment.
About Fidelis Diagnostics Headquartered in Los Angeles, Fidelis Diagnostics is a rapidly growing healthcare company providing a portfolio of innovative diagnostic services to physicians nationwide. Since its inception in 2004, the company has built an exceptional reputation for its quality diagnostics, high standard of business ethics and outstanding service, improving patient health with convenient testing, while reducing overall healthcare costs. In addition to Home Sleep Studies utilizing the innovative FDA-approved WatchPAT device, Fidelis services include ElectroDiagnostics, BreathID H. pylori Testing, Audiology Testing and ABI technology being provided to thousands of physicians across the United States. For more information, visit www.fidelisdiagnostics.com.CONTACT: Agnes Huff Communications Agnes Huff, PhD 310.641.2525 email@example.com KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA INDUSTRY KEYWORD: HEALTH CLINICAL TRIALS MEDICAL DEVICES SOURCE: Fidelis Diagnostics, Inc. Copyright Business Wire 2012 PUB: 11/08/2012 03:20 PM/DISC: 11/08/2012 03:20 PM http://www.businesswire.com/news/home/20121108006753/